Arcus Biosciences Inc

Healthcare · Biotechnology

25.10$ -5.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

Arcus Biosciences Inc (RCUS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 924 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet RCUS
Line item	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	110	–	–	–	190	305	294	287	275	259	239	217	203	176	481	811	772	935	899	839	1,592	1,543	1,477	1,394	1,345	1,254	1,220	1,191	1,095	1,293	1,186	1,252	1,150	1,156	1,075	974	1,139	997	924
Current Assets	100	99	–	–	177	282	267	265	259	245	228	200	193	166	472	797	736	842	746	545	1,262	1,264	1,227	1,101	1,066	1,014	985	881	831	1,064	1,022	1,127	1,016	1,031	946	857	1,007	844	756
Cash	65	-99	–	–	98	198	170	75	71	68	76	79	58	67	285	222	173	390	320	179	148	549	273	218	206	238	230	184	127	185	156	201	150	192	248	238	222	201	150
Cash & Short-Term Investments	–	99	–	–	176	280	266	258	257	242	224	191	188	158	462	782	729	827	721	525	499	1,214	1,173	1,049	1,009	954	930	799	759	995	969	1,089	978	997	911	831	981	822	702
Receivables	0.4	–	–	–	0.0	0.1	0.2	5.1	0.1	0.1	0.1	5.3	0.1	0.3	0.5	3.0	1.7	6.3	3.0	3.1	747	32	39	31	43	36	37	56	42	40	33	21	25	21	20	14	16	7.0	36
Inventory	–	–	–	–	–	0.0	0.0	0.0	–	–	–	0.0	–	–	0.0	0.0	-7.2	–	0.0	–	-762	–	0.0	0.0	-172	-90	-80	-207	–	–	–	–	–	–	–	–	–	–	–
Property, Plant & Equipment	8.6	–	–	–	11	12	13	12	11	11	10	10	9.3	8.8	8.3	8.7	11	15	60	64	32	33	33	34	135	37	45	50	–	–	–	–	–	–	–	–	–	–	–
Goodwill	–	–	–	–	–	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	–	–	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–
Total Liabilities	10	-99	–	–	37	39	39	42	40	37	42	40	39	36	53	267	270	270	294	297	750	747	729	695	688	654	654	671	633	586	551	687	665	625	526	538	508	473	460
Current Liabilities	5.5	–	–	–	13	14	16	17	17	19	27	21	23	21	40	163	122	132	130	143	166	161	164	177	193	179	180	200	184	204	199	215	226	192	210	235	231	209	198
Short-Term Debt	–	–	–	–	3.1	3.6	4.3	6.7	6.0	7.6	16	9.7	9.5	10	20	36	2.9	31	38	55	5.1	–	–	–	3.0	–	57	9.0	11	11	11	11	12	12	12	13	13	13	13
Accounts Payable	3.9	–	–	–	3.8	3.9	5.4	2.1	3.1	2.8	2.4	2.9	4.7	2.4	12	8.1	16	25	17	13	10	18	22	11	20	28	12	17	17	16	15	13	18	22	29	42	42	39	34
Long-Term Debt	–	–	–	–	–	0.0	0.0	0.0	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	–	47	48	48	97	98	99	100	101
Shareholders' Equity	99	99	–	–	154	267	255	245	235	222	197	177	164	141	429	544	502	665	605	543	841	797	747	699	657	600	566	520	462	707	635	565	485	531	549	436	631	524	464
Retained Earnings	-20	–	–	–	-73	-86	-100	-111	-123	-138	-166	-189	-205	-233	-278	-276	-328	-401	-477	-555	-275	-343	-410	-475	-542	-622	-697	-768	-849	-853	-946	-1,038	-1,132	-1,244	-1,244	-1,379	-1,485	-1,613	-1,704
Shares Outstanding	–	25	25	25	25	9.5	43	43	43	44	44	44	44	44	49	65	64	67	70	70	75	71	72	72	73	73	73	75	75	86	91	91	92	98	107	107	107	125	126

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings